Literature DB >> 10074177

Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast.

M Chen1, R T Elder, M Yu, M G O'Gorman, L Selig, R Benarous, A Yamamoto, Y Zhao.   

Abstract

Cell cycle G2 arrest, nuclear localization, and cell death induced by human immunodeficiency virus type 1 Vpr were examined in fission yeast by using a panel of Vpr mutations that have been studied previously in human cells. The effects of the mutations on Vpr functions were highly similar between fission yeast and human cells. Consistent with mammalian cell studies, induction of cell cycle G2 arrest by Vpr was found to be independent of nuclear localization. In addition, G2 arrest was also shown to be independent of cell killing, which only occurred when the mutant Vpr localized to the nucleus. The C-terminal end of Vpr is crucial for G2 arrest, the N-terminal alpha-helix is important for nuclear localization, and a large part of the Vpr protein is responsible for cell killing. It is evident that the overall structure of Vpr is essential for these cellular effects, as N- and C-terminal deletions affected all three cellular functions. Furthermore, two single point mutations (H33R and H71R), both of which reside at the end of each alpha-helix, disrupted all three Vpr functions, indicating that these two mutations may have strong effects on the overall Vpr structure. The similarity of the mutant effects on Vpr function in fission yeast and human cells suggests that fission yeast can be used as a model system to evaluate these Vpr functions in naturally occurring viral isolates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074177      PMCID: PMC104087     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Improvements in protein secondary structure prediction by an enhanced neural network.

Authors:  D G Kneller; F E Cohen; R Langridge
Journal:  J Mol Biol       Date:  1990-07-05       Impact factor: 5.469

2.  HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.

Authors:  W C Goh; M E Rogel; C M Kinsey; S F Michael; P N Fultz; M A Nowak; B H Hahn; M Emerman
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

3.  HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.

Authors:  M A Vodicka; D M Koepp; P A Silver; M Emerman
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

4.  Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint.

Authors:  R T Elder; M Yu; M Chen; S Edelson; Y Zhao
Journal:  Virus Res       Date:  2000-07       Impact factor: 3.303

5.  Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2.

Authors:  M G Lee; P Nurse
Journal:  Nature       Date:  1987 May 7-13       Impact factor: 49.962

6.  Induction of cell differentiation by human immunodeficiency virus 1 vpr.

Authors:  D N Levy; L S Fernandes; W V Williams; D B Weiner
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

7.  Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.

Authors:  S M Lang; M Weeger; C Stahl-Hennig; C Coulibaly; G Hunsmann; J Müller; H Müller-Hermelink; D Fuchs; H Wachter; M M Daniel
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.

Authors:  Y L Lu; P Spearman; L Ratner
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Insertional restoration of beta-galactosidase alpha-complementation (white-to-blue colony screening) facilitates assembly of synthetic genes.

Authors:  J E Cronan; M L Narasimhan; M Rawlings
Journal:  Gene       Date:  1988-10-15       Impact factor: 3.688

10.  Evolution of the primate lentiviruses: evidence from vpx and vpr.

Authors:  M Tristem; C Marshall; A Karpas; F Hill
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

View more
  34 in total

1.  Nuclear targeting of the beta isoform of type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its alpha-helix 7.

Authors:  A Ciruela; K A Hinchliffe; N Divecha; R F Irvine
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.

Authors:  A Deora; L Ratner
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry.

Authors:  Navid Madani; Amy M Hubicki; Ana Luisa Perdigoto; Martin Springer; Joseph Sodroski
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  Characterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeast.

Authors:  Ge Li; Melissa Poulsen; Csaba Fenyvuesvolgyi; Yoko Yashiroda; Minoru Yoshida; J Marc Simard; Robert C Gallo; Richard Y Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

5.  The dose-dependent H2O2 stress response promotes increased survival for Schizosaccharomyces pombe cells expressing HIV-1 Vpr.

Authors:  J Antal; M Pesti
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 6.  HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Authors:  Joshua L Andersen; Erwann Le Rouzic; Vicente Planelles
Journal:  Exp Mol Pathol       Date:  2008-04-25       Impact factor: 3.362

7.  Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R.

Authors:  Sergey Iordanskiy; Yuqi Zhao; Larisa Dubrovsky; Tatiana Iordanskaya; Mongzhong Chen; Dong Liang; Michael Bukrinsky
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

9.  HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome.

Authors:  Ge Li; Robert T Elder; Larisa Dubrovsky; Dong Liang; Tatiana Pushkarsky; Karen Chiu; Tao Fan; Josephine Sire; Michael Bukrinsky; Richard Y Zhao
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions.

Authors:  Guillaume Jacquot; Erwann Le Rouzic; Priscilla Maidou-Peindara; Marion Maizy; Jean-Jacques Lefrère; Vincent Daneluzzi; Carlos M R Monteiro-Filho; Duanping Hong; Vicente Planelles; Laurence Morand-Joubert; Serge Benichou
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.